JTCS Concomitant Website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Article

J Thorac Cardiovasc Surg 2006;132:1289-1290
© 2006 The American Association for Thoracic Surgery


Surgery for Congenital Heart Disease

Discussion

The first 300 words of the full text of this article appear below.

Dr Christopher J. Knott-Craig (Oklahoma City, Okla). I rise to congratulate you on the first major presentation on patients with neonatal Ebstein anomaly and on the continued results that you have shared with us. In your presentation you review a 14-year experience with 16 patients, most of whom underwent RV exclusion and have excellent outcomes based on historical norms.

We also have a good experience with neonatal Ebstein patients, having had the opportunity to operate on 22 of these patients over 12 years; we have taken a different approach in that we have attempted a 2-ventricle repair in all of them with a greater than 70% survival.

Clearly, there is room to do an RV exclusion operation and there is room to do a 2-ventricle repair. The dilemma that we face as surgeons is trying to stratify which patients would do better with one operation versus the other. Can you help us make a decision based on your experience? Do you have any insights that you could share with us based on your most recent experience in this regard?

Dr Reemtsen. I think the million-dollar question is, when should this be done? We think of the RV exclusion as more of a tool to deal with Ebstein anomaly than as an answer. If the valve tissue looks good and we think we can approach a repair and there is a tripartite ventricle with an open RVOT, then we absolutely will attempt to repair the malformation. If we are not able to do, by echocardiogram, an adequate repair, we would do an RV exclusion at that point.

I think the more difficult group is the one in which there is failure at delamination, there is really no identifiable leaflet tissue, and there is an obstructed RVOT. I do not think, at . . . [Full Text of this Article]


Related Article

Current surgical therapy for Ebstein anomaly in neonates
Brian L. Reemtsen, Brian T. Fagan, Winfield J. Wells, and Vaughn A. Starnes
J. Thorac. Cardiovasc. Surg. 2006 132: 1285-1289. [Abstract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.